OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

SARS-CoV-2 incubation period across variants of concern, individual factors, and circumstances of infection in France: a case series analysis from the ComCor study
Simon Galmiche, Thomas Cortier, Tiffany Charmet, et al.
The Lancet Microbe (2023) Vol. 4, Iss. 6, pp. e409-e417
Open Access | Times Cited: 50

Showing 1-25 of 50 citing articles:

Randomized controlled trial of molnupiravir SARS-CoV-2 viral and antibody response in at-risk adult outpatients
Joseph F. Standing, Laura Buggiotti, José Afonso Guerra‐Assunção, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 18

Zoonosis and zooanthroponosis of emerging respiratory viruses
Ahmed Magdy Khalil, Luis Martínez‐Sobrido, Ahmed Mostafa
Frontiers in Cellular and Infection Microbiology (2024) Vol. 13
Open Access | Times Cited: 8

A unifying model to explain frequent SARS-CoV-2 rebound after nirmatrelvir treatment and limited prophylactic efficacy
Shadisadat Esmaeili, Katherine Owens, Jessica Wagoner, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 7

SARS-CoV-2 evolution on a dynamic immune landscape
N. Alexia Raharinirina, Nils Gubela, Daniela Börnigen, et al.
Nature (2025)
Open Access

The Asymptomatic Proportion of SARS‐CoV‐2 Omicron Variant Infections in Households: A Systematic Review
Nancy D. J. Shi, Adrian J. Marcato, Violeta Spirkoska, et al.
Influenza and Other Respiratory Viruses (2024) Vol. 18, Iss. 7
Open Access | Times Cited: 4

Best practices for estimating and reporting epidemiological delay distributions of infectious diseases
Kelly Charniga, Sang Woo Park, Andrei R. Akhmetzhanov, et al.
PLoS Computational Biology (2024) Vol. 20, Iss. 10, pp. e1012520-e1012520
Open Access | Times Cited: 4

flepiMoP: The evolution of a flexible infectious disease modeling pipeline during the COVID-19 pandemic
Joseph C. Lemaitre, Sara L. Loo, Joshua Kaminsky, et al.
Epidemics (2024) Vol. 47, pp. 100753-100753
Open Access | Times Cited: 3

Near-term forecasting of Covid-19 cases and hospitalisations in Aotearoa New Zealand
Michael J. Plank, Leighton M. Watson, Oliver J. Maclaren
PLoS Computational Biology (2024) Vol. 20, Iss. 1, pp. e1011752-e1011752
Open Access | Times Cited: 2

Employee investigation and contact tracing program in a pediatric cancer hospital to mitigate the spread of COVID-19 among the workforce, patients, and caregivers
Diego R. Hijano, Sandra R. Dennis, James M. Hoffman, et al.
Frontiers in Public Health (2024) Vol. 11
Open Access | Times Cited: 2

Latent and incubation periods of Delta, BA.1, and BA.2 variant cases and associated factors: a cross-sectional study in China
Yu Li, Xin'ang Jiang, Qiu Yan, et al.
BMC Infectious Diseases (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 2

Development of a SARS‐CoV‐2 viral dynamic model for patients with COVID‐19 based on the amount of viral RNA and viral titer
D T Yamaguchi, Ryosuke Shimizu, Ryuji Kubota
CPT Pharmacometrics & Systems Pharmacology (2024) Vol. 13, Iss. 8, pp. 1354-1365
Open Access | Times Cited: 2

Epidemiological Parameters of SARS-CoV-2 in the UK during the 2023/2024 Winter: A Cohort Study
Christopher E. Overton, Martyn Fyles, Jonathon Mellor, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2

Antiviral effect of Evusheld in COVID-19 hospitalized patients infected with pre-Omicron or Omicron variants: a modelling analysis of the randomized DisCoVeRy trial
M. Beaulieu, Alexandre Gaymard, Clément Massonnaud, et al.
Journal of Antimicrobial Chemotherapy (2024) Vol. 79, Iss. 11, pp. 2887-2895
Open Access | Times Cited: 2

A data set of symptoms and needs of individuals affected by COVID-19
H. B. Stanley, Moustafa Bensafi
Scientific Data (2024) Vol. 11, Iss. 1
Open Access | Times Cited: 1

COVID-19-associated cerebral microbleeds in the general population
Malini Vendela Sagar, Neus Rodeja Ferrer, Mostafa Mehdipour Ghazi, et al.
Brain Communications (2024) Vol. 6, Iss. 3
Open Access | Times Cited: 1

Outdoor air pollution as a risk factor for testing positive for SARS-CoV-2: A nationwide test-negative case-control study in the Netherlands
Mariana Simões, Jelle Zorn, Lenny Hogerwerf, et al.
International Journal of Hygiene and Environmental Health (2024) Vol. 259, pp. 114382-114382
Open Access | Times Cited: 1

Assessment of fever screening at airports in detecting domestic passengers infected with SARS-CoV-2, 2020–2022, Okinawa prefecture, Japan
Yoshihiro Takayama, Yining S. Xu, Yusuke Shimakawa, et al.
BMC Infectious Diseases (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1

Multi-objective optimization of activity-travel policies for epidemic control: Balancing health and economic outcomes on socio-economic segments
Cloe Cortes Balcells, Rico Krueger, Michel Bierlaire
Transportation Research Interdisciplinary Perspectives (2024) Vol. 27, pp. 101183-101183
Open Access | Times Cited: 1

Ventilation efficiency and improvements for displacement ventilation systems during heating: A case study of a ward with vertical induction units
Shaoyu Sheng, Toshio Yamanaka, Tomohiro Kobayashi, et al.
Building and Environment (2024) Vol. 266, pp. 112037-112037
Open Access | Times Cited: 1

Modeling the Impact of Ensitrelvir on SARS-CoV-2 Dynamics and Its Application for Assessment of Transmission Mitigation of Patients with COVID-19
D T Yamaguchi, Masaya Saito, Ayano Hata, et al.
Infectious Diseases and Therapy (2024) Vol. 13, Iss. 11, pp. 2377-2393
Open Access | Times Cited: 1

A unifying model to explain high nirmatrelvir therapeutic efficacy against SARS-CoV-2, despite low post-exposure prophylaxis efficacy and frequent viral rebound
Shadisadat Esmaeili, Katherine Owens, Jessica Wagoner, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 4

Page 1 - Next Page

Scroll to top